My current research is focusing on understanding how cancer and cancer chemotherapeutics impacts on sensitisation and pain. I am focusing on understanding the ability of extracellular vesicles (EVs) to transfer biologically active compounds to alter neurodevelopment.

Part of this work has involved visualising EV uptake in recipient cells. We commonly use size-exclusion chromatography (SEC) (qEV Original, Izon) or ultracentrifugation to simultaneously collect cancer EVs and remove unbound dye.

Hannah Jackson Drawing showing Vesi-SEC micro in use

Workflow for isolation, labelling, and imaging of sEV cell uptake.

Schematic demonstrating isolation of extracellular vesicles (EVs), followed by their labelling with Membright-560 live cell dye. To remove unbound dye, EVs either underwent ultracentrifugation at 100,000g for 70 minutes or were loaded onto Vesi-SECs and centrifuged at 1000g for 1 minute. Finally, the labelled EV uptake is visualized and analysed using the ThermoFisher EVOS M7000 Imaging System.

While effective, these methods are both time-consuming and result in a decrease in overall EV yield. To address these limitations, we have incorporated the Vesi-SEC micro from Vesiculab into our protocol. This innovative solution offers a fast and high-throughput alternative. Following the incubation of EVs with a membrane dye, the Vesi-SEC micro enables the enrichment and purification of EVs in approximately one minute. This not only significantly reduces processing time but also minimises sample background, likely due to the effective removal of unbound dye, enhancing the clarity and reliability of our results (as illustrated in Figure 1).

Neurons uptake Membright-labelled sEVs

Experimental Section

SEVs were incubated with BioTracker™ MemBright 560 Live Cell Dye (SCT084, Sigma-Aldrich) at a final concentration of 200 nM in PBS for 30 minutes at room temperature in the dark. After incubation, 50 µL of PBS was added to each sample. To remove free dye, SEVs were either ultracentrifuged at 100,000 xg for 70 minutes at 4°C or loaded onto Vesi-SEC micro-size exclusion chromatography spin-columns (Vesiculab, Nottingham, UK). SEVs were used immediately after isolation. As a control, PBS alone underwent the same process as SEVs, labelled with MemBright, and cleaned using ultracentrifugation or Vesi-SEC columns. Then, 50 µL of cleaned SEVs (1×10^10 particles/mL) or PBS controls were added to recipient cells and visualised at various time points using a ThermoFisher EVOS M7000 Imaging System with a 20X objective.

Hannah Jackson Profile Picture

Hannah Kate Jackson

Postdoctoral Research Fellow at The University of Nottingham

My research has mainly been dominated by an interest in extracellular vesicles (EVs). I began my research career investigating the role of EVs in the paediatric brain tumour, medulloblastoma. I then spent a couple of years at the University of Cambridge where I worked on bioengineering EVs as a novel platform for effective SARS-CoV-2 vaccine development. My current work is now focusing on understanding how cancer and cancer chemotherapeutics impacts on sensitisation and pain.

For more information on Vesi-SEC micro, please visit our product page.